Liothyronine treatment in psychotic and nonpsychotic children under 6 years.
D000367:Age Factors; D001925:Brain Damage, Chronic / Q000188:drug therapy; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003913:Dextroamphetamine / Q000008:administration & dosage / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy; D008607:Intellectual Disability / Q000188:drug therapy; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D010919:Placebos; D012075:Remission, Spontaneous; D012561:Schizophrenia, Childhood / Q000188:drug therapy*; D013610:Tachycardia / Q000139:chemically induced; D013960:Thyroid Function Tests; D014284:Triiodothyronine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D010919:Placebos; D014284:Triiodothyronine; D003913:Dextroamphetamine